Lipid Multiparticulates (LMP) are an innovation originally developed to enhance the performance of pharmaceutical products. This technology is now available for consumer health and nutrition applications and can help to improve the performance of active nutritionals in three ways:
Lonza’s proprietary Melt Spray Congeal (MSC) manufacturing process is used to produce LMP’s. They are spherical in shape and characterized as microspheres formulated to contain discrete units of active nutritional ingredients including: botanicals, vitamins and amino acids. The process allows for tighter control of particle size ranging from 50 – 300 microns. The ability to precisely deliver a metered dose of actives combined with the controlled particle size of LMP helps to improve gut distribution. This advanced technology is aligned with growing consumer demand for clean label products through a solvent-free manufacturing process.
LMP microspheres have excellent flow properties, making them ideal for inclusion into a broad range of finished dose formats including:
In addition to our pharmaceutical development and manufacturing site in Bend, OR, Lonza has installed capacity exclusively for the nutrition market in Greenwood, SC with a co-located product development team ready to assist in the ideation of custom formulations. This site is serving development and manufacturing in both the Americas and European markets.